Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 28,235 | 9,097 | 2,216 | 1,410 | 6,029 |
| Marketable Securities | 30,161 | 30,178 | 21,495 | 14,007 | N/A |
| TOTAL | $59,901 | $43,828 | $25,320 | $16,727 | $6,228 |
| Non-Current Assets | |||||
| PPE Net | 192 | 71 | 41 | 54 | 12 |
| Other Non-Current Assets | 9 | 9 | 9 | 9 | 9 |
| TOTAL | $200 | $80 | $50 | $63 | $21 |
| Total Assets | $60,102 | $43,908 | $25,370 | $16,789 | $6,249 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,794 | 1,814 | 851 | 1,366 | 264 |
| Accrued Expenses | 1,647 | 4,041 | 1,289 | 281 | 570 |
| TOTAL | $3,441 | $5,855 | $2,140 | $1,647 | $834 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,185 | 2,811 | 1,839 | 521 | 1,655 |
| TOTAL | $1,185 | $2,811 | $1,839 | $521 | $1,655 |
| Total Liabilities | $4,625 | $8,666 | $3,978 | $2,167 | $2,489 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,880 | 81,445 | 54,146 | 41,421 | 24,742 |
| Common Shares | 83 | 69 | 54 | 41 | 25 |
| Retained earnings | -90,076 | -69,843 | -54,334 | -42,179 | -38,103 |
| TOTAL | $55,476 | $35,242 | $21,391 | $14,622 | $3,761 |
| Total Liabilities And Equity | $60,102 | $43,908 | $25,370 | $16,789 | $6,249 |